![Jennifer Michaelson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 3 Mio $ am 31.05.2026
Jennifer Michaelson currently works at Cullinan Therapeutics, Inc., as Chief Scientific Officer from 2023.
Dr. Michaelson also formerly worked at Jounce Therapeutics, Inc., as Director-Tumor Immunology, Cullinan Oncology LLC, as Chief Development Officer-Biologics from 2020 to 2022, and Celsius Therapeutics, Inc., as Head-Biologics in 2017.
Dr. Michaelson received her undergraduate degree from Princeton University and doctorate degree from Albert Einstein College of Medicine, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.05.2026 | 166.844 ( 0,27 % ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Corporate Officer/Principal | 01.12.2017 |
| JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.07.2017 |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
